Hepatitis B (krónikus): vizsgálatok itt: Kína
104 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 1. fázisNot yet taking people in KínaACT201 Injection in Participants With Chronic Hepatitis B (CHB) on Nucleos(t)Ide Analog Therapy - Phase Ib
- Where
- Beijing, Wuhan, Xiamen, Xi'an
- Életkor
- 18 év to 65 év
- People
- 40
- Run by
- Xiamen Amoytop Biotech Co., Ltd.
See details and how to joinNCT07929805 - 1. fázisCsak meghívásosA Phase I Clinical Trial of CPU-YL01 Injection in Patients With Chronic Hepatitis B.
- Where
- Beijing, Nanjing, Zhengzhou
- Életkor
- 18 év to 70 év
- People
- 74
- Run by
- Jiangsu Chuangyuan Life Science and Technology Co., Ltd.
See details and how to joinNCT07918456 - 1. fázisNot yet taking people in KínaPhase Ia/Ib Trial of SCTA02A Injection in Healthy Adults and Patients With Chronic Hepatitis B
- Where
- Beijing
- Életkor
- 18 év to 65 év
- People
- 60
- Run by
- Sinocelltech Ltd.
See details and how to joinNCT07903831 - 2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Combination Therapy of BRII-179, BRII-835 and PEG-IFNα in Participants With Chronic Hepatitis B Virus (HBV) Infection (ENHANCE)
- Where
- Beijing, Chengdu, Guangzhou, Hangzhou, Shanghai, Shenzhen
- Életkor
- 18 év to 60 év
- People
- 250
- Run by
- Brii Biosciences Limited
See details and how to joinNCT06650852 - 1. fázisNot yet taking people in KínaA Clinical Study of AHB-121 in Healthy Participants and Chronic Hepatitis B (CHB) Participants
- Where
- Shanghai
- Életkor
- 18 év to 65 év
- People
- 110
- Run by
- Ausper Biopharma Co., Ltd.
See details and how to joinNCT07884864 - 4. fázisCsak meghívásosTAF vs TDF During the Pregancy
- Where
- Guangzhou
- Életkor
- 20 év to 40 év
- People
- 210
- Run by
- The Third Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT07542951 - 2. fázisTaking peoplePhase 2 Study of AHB-137 in HBeAg Negative Chronic Hepatitis B (CHB) Participants in Asia Pacific Region
- Where
- Hong Kong
- Életkor
- 18 év to 65 év
- People
- 84 worldwide
- Run by
- AusperBio Therapeutics Inc.
See details and how to joinNCT07370207 - 3. fázisNot yet taking people in KínaClinical Trial of TQA3605 Tablet in Combination With Nucleos(t)Ide Analogues(NAs) Versus NAs Alone for the Treatment of Patients With Chronic Hepatitis B Virus Infection Who Have Undergone Treatment and Exhibit Low Viral Load or Poor Response
- Where
- Anyang, Baoji, Beijing, Changchun, Changsha, Changzhi, Chengdu, Chifeng, Chongqing, Dalian, Deyang, Foshan, Fuzhou, Guangzhou, Guiyang, Haikou, Hangzhou, Harbin, Hefei, Hengyang, Huaihua, Jinan, Jingzhou, Kunming, Langfang, Lanzhou, Liaocheng, Lishui, Liuzhou, Lüliang, Luoyang, Meishan, Mudanjiang, Nanchang, Nanjing, Ningbo, Puyang, Qingdao, Shanghai, Shenyang, Shenzhen, Shijiazhuang, Suzhou, Taiyuan, Taizhou, Tianjin, Ürümqi, Weifang, Wenzhou, Wuhu, Wuwei, Xiamen, Xi'an, Xi’an, Xining, Yuncheng, Zhengzhou, Zhuhai, Zunyi
- Életkor
- 18 év to 65 év
- People
- 930
- Run by
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
See details and how to joinNCT07797231 - No phaseTaking peopleImpact of Functional Cure of Chronic Hepatitis B on Patient-Reported Outcomes (PROs)
- Where
- Guangzhou
- Életkor
- 18 év to 65 év
- People
- 400
- Run by
- Zhiliang Gao
See details and how to joinNCT07855029 - 2. fázisTaking peopleA Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (A)
- Where
- Chongqing
- Életkor
- 18 év to 60 év
- People
- 1200
- Run by
- The Second Affiliated Hospital of Chongqing Medical University
See details and how to joinNCT07852091 - 2. fázisTaking peopleA Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (B)
- Where
- Chongqing
- Életkor
- 18 év to 60 év
- People
- 1200
- Run by
- The Second Affiliated Hospital of Chongqing Medical University
See details and how to joinNCT07845058 - 2. fázisTaking peopleA Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (A)
- Where
- Chongqing
- Életkor
- 18 év to 70 év
- People
- 120
- Run by
- The Second Affiliated Hospital of Chongqing Medical University
See details and how to joinNCT05769816 - 1. fázisNot yet taking people in KínaSafety, Tolerability, Pharmacokinetic and Pharmacodynamic Characteristics of ACT500 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease Complicated With Chronic Hepatitis B
- Where
- Beijing, Shanghai, Ürümqi, Xiamen
- Életkor
- 18 év to 60 év
- People
- 24
- Run by
- Xiamen Amoytop Biotech Co., Ltd.
See details and how to joinNCT07589400 - No phaseNot yet taking people in KínaSequential PD-1 Antibody and Pegylated Interferon Therapy for Nucleos(t)Ide Analogue-suppressed Chronic Hepatitis B
- Where
- Jinan, Taiyuan, Xi'an, Xi’an
- Életkor
- 18 év to 55 év
- People
- 60
- Run by
- Beijing 302 Hospital
See details and how to joinNCT07809165 - 2. fázisTaking peopleA Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (B)
- Where
- Chongqing
- Életkor
- 18 év to 70 év
- People
- 120
- Run by
- The Second Affiliated Hospital of Chongqing Medical University
See details and how to joinNCT05771402 - 4. fázisTaking peopleASC22 Combined With Peg-IFNa in Achieving Functional Cure in Patients With Chronic Hepatitis B Virus Infection
- Where
- Chongqing
- Életkor
- 18 év to 60 év
- People
- 120
- Run by
- The Second Affiliated Hospital of Chongqing Medical University
See details and how to joinNCT07573943 - No phaseTaking peopleSafety and Efficacy of TAF to Prevent MTCT of HBV in Middle/Late Pregnancies With High HBV DNA Load
- Where
- Guangzhou
- Életkor
- 20 év to 40 év
- People
- 200
- Run by
- Xingfei Pan
See details and how to joinNCT05466071 - 1. fázisTaking peopleA Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of BRII-5395 in Combination With Sintilimab and Bevacizumab in Advanced Hepatitis B Virus Related Hepatocellular Carcinoma
- Where
- Beijing
- Életkor
- 18 év to 70 év
- People
- 21
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07557251 - No phaseNot yet taking people in KínaHCC Risk Prediction Model Based on Multimodal Data in Chronic Hepatitis B
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 2000
- Run by
- Beijing Friendship Hospital
See details and how to joinNCT07780357 - 1/2. fázisTaking peopleStudy of LW231 in Participants With Chronic Hepatitis B
- Where
- Hangzhou
- Életkor
- 18 év to 60 év
- People
- 270
- Run by
- Shanghai Longwood Biopharmaceuticals Co., Ltd.
See details and how to joinNCT07179575 - No phaseTaking peopleLong-term Follow-up Study to Evaluate Participants With Chronic Hepatitis B (CHB) Previously Treated With AHB-137 Injection
- Where
- Beijing, Changchun, Changhou, Changsha, Chengdu, Chongqing, Foshan, Fuzhou, Guangzhou, Haikou, Hangzhou, Hefei, Kunming, Lanzhou, Liuzhou, Nanchang, Nanjing, Nanning, Shanghai, Shenyang, Shenzhen, Taiyuan, Wuhan, Xiamen, Xi’an, Zhengzhou, Zhenjiang, Zunyi
- Életkor
- 18 év and over
- People
- 200
- Run by
- Ausper Biopharma Co., Ltd.
See details and how to joinNCT07146100 - No phaseTaking peoplePeg IFNα-2b Therapy for Unresectable Mid to Late Stage HBV-HCC
- Where
- Nanjing
- Életkor
- 18 év and over
- People
- 33
- Run by
- Jinling Hospital, China
See details and how to joinNCT07769827 - 1. fázisTaking peopleA Phase I Clinical Trial to Evaluate HECN30227 Injection in Healthy Subjects and Subjects With Chronic Hepatitis B
- Where
- Hefei
- Életkor
- 18 év to 65 év
- People
- 78
- Run by
- Sunshine Lake Pharma Co., Ltd.
See details and how to joinNCT07771140 - 1. fázisTaking peopleACT201 Injection in Healthy Participants and Participants With Chronic Hepatitis B (CHB)
- Where
- Shanghai
- Életkor
- 18 év to 65 év
- People
- 72
- Run by
- Xiamen Amoytop Biotech Co., Ltd.
See details and how to joinNCT07741461 - 2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of AHB-137 Injection in Participants With Chronic Hepatitis B (CHB)
- Where
- Beijing, Changzhou, Chengdu, Chongqing, Guangzhou, Hangzhou, Jilin City, Nanning, Shenzhen, Xiamen, Zhengzhou
- Életkor
- 18 év to 65 év
- People
- 200
- Run by
- Ausper Biopharma Co., Ltd.
See details and how to joinNCT07137910